# Prospection

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/prospection

- Industry: Software
- Headquarters: Sydney, Australia
- Website: www.prospection.com
- Total disclosed funding: $43M
- Latest round: Series B (Sep 17, 2021)
- Investors on record: 5

## About

Prospection, based in Sydney, NSW, Australia, specializes in patient-centric intelligence solutions for the pharmaceutical industry, enhancing insights into patient journeys through advanced data analytics.Founded in 2012 in Sydney, Australia, Prospection focuses on transforming healthcare data into actionable insights. The company has successfully raised AUD 49.765 mn in its latest funding round, Series B, led by Ellerston Capital on September 17, 2021, with additional participation from Horizons Ventures, Main Sequence Ventures, Novotech Holdings, and Pacific Estate Group Limited. Eric Chung and Peter Cronin are the founders, while Daniel West serves as the CEO.Prospection’s Uplift Care-and-Share product offers an advanced suite of solutions that leverage its proprietary Patient-centric Intelligence Core technology. This platform enables pharmaceutical companies to gain deep insights into patient journeys, tracking care-and-share metrics through leading indicators. Uplift serves over 25 major pharmaceutical organizations across more than 100 medical indications, assisting them in understanding patient behaviors and treatment landscapes in regions such as North America, Europe, and Asia.The revenue model for Uplift Care-and-Share is based on subscription services that provide clients ongoing access to comprehensive insights and analytics. This structured pricing plan accommodates various levels of analytics, allowing clients to tailor their engagement based on their specific needs. Key offerings include Prospection AI and the award-winning ProGPT, which help pharmaceutical brands efficiently utilize patient-centric intelligence.Following the recent Series B funding round in September 2021, Prospection plans to expand its operations in the UK and US healthcare markets. The funding will be allocated to enhance product capabilities, aiding healthcare providers with clinical decision support during patient appointments. Furthermore, the strategy includes broadening its customer base to support healthcare payors, governments, and patients, while also enhancing the platform to integrate additional data sets.

## Funding rounds

- Series B, Sep 17, 2021, $36M — Ellerston Capital, Horizons Ventures, Main Sequence Ventures, Novotech Holdings, Pacific Estate Group Limited
- Seed, Dec 19, 2019, $6.9M — Horizons Ventures, Main Sequence Ventures

## Investors

- Horizons Ventures — Seed, Series B
- Main Sequence Ventures (https://capitalatlas.ai/funds/main-sequence-ventures) — Seed, Series B
- Ellerston Capital (https://capitalatlas.ai/funds/ellerston-capital) — Series B
- Novotech Holdings — Series B
- Pacific Estate Group Limited — Series B